Kelly Stratton, M.D. (IMAGE)

University of Oklahoma

Kelly Stratton, M.D.

Caption

OU Health urologic oncologist Kelly Stratton, M.D., is leading a prostate cancer clinical trial studying the combination of relugolix and enzalutamide.

Credit

University of Oklahoma

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.